TickerFacts.

Sunshine Biopharma Inc. (SBFM): Cost of Revenue

Annual figures by period end, from SEC filings.

$24.05M
Year ended 2025-12-31
$24.64M
Trailing 12 months to 2026-06-30
+108.6%
3-year compound annual growth
n/m
5-year compound annual growth
$24.20M2017-12-31: $02018-12-31: $02019-12-31: $11.1K2020-12-31: $25.8K2021-12-31: $117.8K2022-12-31: $2.65M2023-12-31: $15.75M2024-12-31: $24.20M2025-12-31: $24.05M$24.05M
2017-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$24.05M-0.6%2026-04-03, From 2025-01-01
2024-12-31$24.20M+53.6%2026-04-03, From 2024-01-01
2023-12-31$15.75M+494.7%2025-04-01, From 2023-01-01
2022-12-31$2.65Mn/m2024-03-28, From 2022-01-01
2021-12-31$117.8K+355.9%2023-04-04, From 2021-01-01
2020-12-31$25.8K+133.9%2022-03-21, From 2020-01-01
2019-12-31$11.1Kn/a2021-03-30, From 2019-01-01
2018-12-31$0n/a2020-05-01, From 2018-01-01
2017-12-31$0n/a2019-04-12, From 2017-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Sunshine Biopharma Inc. (SBFM)2025-12-31$24.05M-0.6%
Lftd Partners Inc. (LIFD)2025-12-31$24.30M-1.1%
Earth Science Tech, Inc. (ETST)2026-03-31$10.21M+15.8%
Verrica Pharmaceuticals Inc. (VRCA)2024-12-31$2.60M+420.0%
BGM Group Ltd. (BGM)2025-09-30$31.61M+50.6%
Bioharvest Sciences Inc. (BHST)2025-12-31$14.03M+24.8%
Zomedica Corp. (ZOMDF)2025-12-31$10.35M+26.3%
Integrated Biopharma Inc (INBP)2026-06-30$43.07M-11.7%
Cumberland Pharmaceuticals Inc (CPIX)2025-12-31$6.67M+1.2%

Compare SBFM, LIFD, ETST, VRCA side by side · Screen every company in Pharmaceutical Preparations ↗